Clinical Trial Update: Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures [Phase 3]

View source ↗

Summary

A Phase 3 open-label, randomized, active-controlled study evaluating levetiracetam as monotherapy for partial-onset seizures has completed; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma SA | Conditions: Epilepsy, Partial Seizures | Phase 3 | Status: COMPLETED | Results posted: 2016-08-11